Nipro newsletter April 2026
Carterra 23/09/25
LB Bohle – 10.06.2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

DDL 2026
Merxin March 2026
Terumo 05/01
Nipro April 2026
Volume 15 Issue 2

Unlocking the Potential of Drug Discovery Labs with Automation

Trying to achieve more without increasing costs, sacrificing quality, or slowing down growth is a constant mission for any expanding business or industry – but it is...
Continue Reading →
Volume 15 Issue 2

Gene Edited iPSCs May Find a Place in Allogeneic Therapies

An Introduction to Pluripotency Pluripotent: adjective; capable of giving rise to many different cell types. This is the hallmark characteristic of the induced pl...
Continue Reading →
News

A dose of history: which drugs have truly changed the world?

?     Pharmacy2U launches a new interactive timeline celebrating the most important medical discoveries and drugs that changed the face of medici...
Continue Reading →
News

XenoGesis and BioAscent forge alliance to offer enhanced integrated drug discovery services

XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal c...
Continue Reading →
News

Almac Discovery to share latest developments in first-in-class DUB inhibitors at the at 8th Proteasome and Autophagy Congress

Almac Discovery, a biopharmaceutical company with a key research focus in the area of deubiquitylating enzyme therapeutic discovery, has had its work recognised ...
Continue Reading →
News

BioAscent establishes integrated drug discovery services offering

Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences Dr Phil Jones  BioAscent Discove...
Continue Reading →
Biopharma group march 2026
Silgan March 2026
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Aptar – 08/01/2026
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025